Echinacea stands as the world's leading herbal supplement because it generates $168 million annually in U.S. sales through its immune system benefits. The rising market demand has created new threats to product safety due to Echinacea adulteration, Echinacea mislabelling, species substitution, contamination and incorrect labelling, which requires better supply-chain management and testing methods to reduce herbal supplement adulteration risks.
BAPP Bulletin Highlights Echinacea Adulteration and Mislabelling Risks in Herbal Formulation Supplements
Echinacea stands as the world’s leading herbal supplement because it generates $168 million annually in U.S. sales through its immune system benefits. The rising market demand has created new threats to product safety due to Echinacea adulteration, Echinacea mislabelling, species substitution, contamination and incorrect labelling, which requires better supply-chain management and testing methods to reduce herbal supplement adulteration risks.
The ingredient authenticity stands as a vital factor which protects consumers from harm while ensuring businesses follow rules and their products deliver expected results. Accurate identification of plant species prevents contamination, harmful substitutions, and mislabelled formulations, strengthening customer trust in botanical supplements and herbal formulation integrity.
BAPP’s Role:
The Botanical Adulterants Prevention Program (BAPP) protects herbal product quality through scientific guidance and adulteration alerts and validated testing resources. The system enables manufacturers to confirm product authenticity reduce botanical adulteration prevention concerns and safeguard their products from counterfeiting while maintaining superior quality standards throughout the botanical supplement market. BAPP Bulletin report also supports botanical product development services by providing insights into authentic ingredient sourcing and quality verification. [1]
Latest Findings on Echinacea Adulteration:
Research on Echinacea contamination reveals that numerous supplements contain fake Echinacea species including E. purpurea and E. angustifolia and E. pallida. The analysis revealed that products contained unmarked botanicals and wrong plant sections and unrelated botanicals which indicated both unintentional contamination and intentional economic substitution. These observations directly align with BAPP findings on Echinacea adulteration. These findings are critical for companies offering ayurvedic formulation services that rely on authentic herbal inputs.[2]
The main adulterants in Echinacea products consist of unlisted Echinacea species and root substitution with less expensive aerial parts and
- Unlisted Echinacea species
- Root substitution with cheaper aerial parts
- Risks of adulterated Echinacea supplements through addition of
- Cistanche species
- American feverfew (Parthenium integrifolium) roots
Multiple Echinacea species appear in documented cases of product manufacturing even though labels indicate single-species content. Manufacturers use multiple Echinacea species in their products while labeling them as single-species products and they replace expensive root materials with less costly alternatives and add botanicals like Cistanche or feverfew—clear cases of supplement mislabelling risks and Echinacea adulteration. [3]
Echinacea Ingredients: Reasons for Adulteration and Adulterant Plant Parts:
Ingredient Adulterated | Part Adulterated | Reason for Adulteration | Part / Material Used for Adulteration |
Echinacea angustifolia | Root | Inadvertent blending during processing | E. purpurea or E. pallida roots; leaf extracts |
Echinacea purpurea | Root | Economically motivated (intentional) | Cistanche deserticola root; Parthenium integrifolium root |
Echinacea pallida | Root | Inadvertent mixing during harvesting | Aerial parts (leaves) mixed with roots |
Echinacea spp. | Processed forms (powders/extracts) | Substitution for cost reduction | Cistanche spp. roots; Parthenium integrifolium roots |
Echinacea spp. | Multi-ingredient blends | Accidental or intentional blending | Leaf or root extracts from other Echinacea species |
Regulatory & Quality Control Specifications for Echinacea (Purpurea, Angustifolia, Pallida):
Species | Plant Part | Key QC Specifications | Notes |
Echinacea purpurea | Root / Root Extract (Powdered) | ≥ 4% total phenols; ≥ 0.025% alkamides | Based on USP monograph. |
E. purpurea | Aerial parts / Herb | Cichoric acid ≥ 2–4%; total polyphenols ~4–7% | Depends on extraction method.[4] |
Echinacea angustifolia | Root (raw herb) | ≥ 0.075% alkamides; ≥ 0.5% total phenolics | High-quality standards often target ≥1% echinacoside. |
Echinacea pallida | Root (raw herb) | Typically lower phenolics; echinacoside around ~0.34%[5] | Specs vary; requires strong sourcing & internal QC. |
FDA Regulatory Definitions of Adulteration & Mislabelling
Under the Federal Food, Drug, and Cosmetic Act (FD&C Act), adulteration is defined mainly in Section 402 (21 U.S.C. §342):[6]
- A product becomes adulterated when it contains dangerous or toxic substances.
- A product becomes adulterated when essential components get extracted or watered down or replaced with different substances to create false impressions about product quality or strength.
The FDA defines dietary supplement adulteration through two conditions which state that products become adulterated when they contain dangerous dietary ingredients or when they include new dietary ingredients (NDIs) without proper safety documentation and FDA approval.
The FDA also recognizes Economically Motivated Adulteration (EMA)—deliberate substitution, dilution, or mislabelling for financial gain.
Relevance to BAPP (Botanical Adulterants Prevention Program):
- The findings presented in BAPP Bulletins match the definitions that FDA uses.
- The practice of replacing Cistanche with Echinacea falls under Section 402(b) adulteration because it involves swapping out ingredients.
- The practice of incorrect Echinacea species identification or combination violates both product identity and quality standards which results in product adulteration and misbranding.
- The addition of botanical ingredients without proper documentation or FDA approval leads to Section 402(f) adulteration.
- These practices are key considerations in botanical product development services and ayurvedic formulation services, ensuring regulatory and safety compliance.
Regulatory Expectation:
Companies must follow FDA Good Manufacturing Practices (GMPs) to stop adulteration by performing correct identity tests and using proper labeling and validated supply chains and safety documentation.
The protection of consumers depends on complete adherence to Sections 402(b) and 402(f) for maintaining product purity. These measures reduce risks and support safe herbal formulation practices.
Conclusion:
Echinacea adulteration—including species substitution, mislabelling, and root replacement with cheaper parts—poses significant safety, quality, and regulatory risks. Global authorities such as the FDA, EMA, and CITES require accurate species identification, validated testing, and strong supply-chain governance to prevent misbranding and economic adulteration.
Food Research Lab supports manufacturers with botanical authentication, phytochemical profiling, regulatory-aligned assessment, ayurvedic formulation services, botanical product development services, and herbal formulation standardization. FRL verifies whether Echinacea raw materials or supplements show signs of Echinacea adulteration, herbal supplement adulteration, or supplement mislabelling risks, and assists in developing compliant, high-quality formulations aligned with BAPP findings and global standards.
Partnering with FRL ensures companies can safely market authentic, fully compliant herbal products while maintaining consumer trust and regulatory assurance.
Reference:
- (2025, July 29). BAPP Bulletin puts echinacea adulteration under the microscope. NutraIngredients. Retrieved from https://www.nutraingredients.com/Article/2025/07/29/bapp-bulletin-puts-echinacea-adulteration-under-the-microscope/?utm
- Harnly, J. M., et al. (2024). Estimating the extent of adulteration of popular herbs — Echinacea root or herb. Natural Product Reports. https://doi.org/10.1039/d4np00014e
- (n.d.). Adulteration of echinacea (Echinacea purpurea, Echinacea angustifolia and Echinacea pallida). Retrieved from https://www.researchgate.net/publication/394407598_Adulteration_of_echinacea_Echinacea_purpurea_Echinacea_angustifolia_and_Echinacea_pallida
- (n.d.). Echinacea purpurea Extract – Cichoric Acid. KingSci. Retrieved from https://www.kingsci.com/immunity-enhancement-ingredients/echinacea-purpurea-extract/echinacea-purpurea-extract-cichoric-acid.html
- (2001). Echinacea standardization: analytical methods for phenolic compounds and typical levels in medicinal species. Retrieved from https://pubmed.ncbi.nlm.nih.gov/11308313/
- S. Government. (n.d.). Food adulteration (21 U.S.C. § 342). Justia U.S. Code. Retrieved from https://law.justia.com/codes/us/title-21/chapter-9/subchapter-iv/sec-342/
Let’s create something Innovative and Delicious together
Food Research Lab strives for excellence in new Food, Beverage and Nutraceutical Product Research and Development by offering cutting edge scientific analysis and expertise.